Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its upcoming participation in two major investor conferences in September 2025. The company's management will engage in fireside chats at the Citi 2025 Biopharma Back to School Summit on September 3 at 9:00 a.m. ET and the 2025 Wells Fargo Healthcare Conference on September 4 at 9:30 a.m. ET.
Both presentations will be available via live webcast through Kiniksa's website investor section, with replays accessible within 48 hours after each event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha annunciato la sua partecipazione a due importanti conferenze per investitori a settembre 2025. La direzione terrà dei colloqui informali al Citi 2025 Biopharma Back to School Summit il 3 settembre alle 9:00 ET e al 2025 Wells Fargo Healthcare Conference il 4 settembre alle 9:30 ET.
Entrambe le presentazioni saranno trasmesse in diretta via webcast nella sezione investor del sito di Kiniksa, con le registrazioni disponibili entro 48 ore da ciascun evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha anunciado su participación en dos importantes conferencias para inversores en septiembre de 2025. La dirección mantendrá charlas informales en el Citi 2025 Biopharma Back to School Summit el 3 de septiembre a las 9:00 a.m. ET y en el 2025 Wells Fargo Healthcare Conference el 4 de septiembre a las 9:30 a.m. ET.
Ambas presentaciones se emitirán en directo por webcast a través de la sección de inversores del sitio web de Kiniksa, y las reproducciones estarán disponibles dentro de las 48 horas posteriores a cada evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA)는 2025년 9월에 열리는 두 건의 주요 투자자 컨퍼런스에 참가한다고 발표했습니다. 경영진은 9월 3일 오전 9시(동부시간)에 열리는 Citi 2025 Biopharma Back to School Summit과 9월 4일 오전 9시 30분(동부시간)에 열리는 2025 Wells Fargo Healthcare Conference에서 파이어사이드 채팅에 참여합니다.
두 발표 모두 Kiniksa 웹사이트의 투자자 섹션을 통해 라이브 웹캐스트로 시청할 수 있으며, 각 행사 종료 후 48시간 이내에 다시보기로 제공됩니다.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) a annoncé sa participation à deux grandes conférences investisseurs en septembre 2025. La direction participera à des discussions informelles lors du Citi 2025 Biopharma Back to School Summit le 3 septembre à 9h00 ET et du 2025 Wells Fargo Healthcare Conference le 4 septembre à 9h30 ET.
Les deux présentations seront diffusées en direct via webcast dans la section investisseurs du site de Kiniksa, et les rediffusions seront disponibles dans les 48 heures suivant chaque événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im September 2025 angekündigt. Das Management wird am Citi 2025 Biopharma Back to School Summit am 3. September um 9:00 Uhr ET und am 2025 Wells Fargo Healthcare Conference am 4. September um 9:30 Uhr ET in Fireside-Chats auftreten.
Beide Präsentationen werden als Live-Webcast in der Investorensektion der Kiniksa-Website verfügbar sein; Aufzeichnungen stehen jeweils innerhalb von 48 Stunden nach der Veranstaltung zur Verfügung.
- None.
- None.
LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in September:
- Citi 2025 Biopharma Back to School Summit on Wednesday, September 3 at 9:00 a.m. Eastern Time
- 2025 Wells Fargo Healthcare Conference on Thursday, September 4 at 9:30 a.m. Eastern Time
A live webcast of Kiniksa’s presentations will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the events will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
FAQ
When is Kiniksa Pharmaceuticals (KNSA) presenting at the Citi Biopharma Summit 2025?
When is Kiniksa's (KNSA) presentation at the Wells Fargo Healthcare Conference 2025?
How can investors access Kiniksa Pharmaceuticals' (KNSA) conference presentations?
When will the replay of Kiniksa's (KNSA) conference presentations be available?
